Skip to main content
Equibles

VANGUARD PORTFOLIO MANAGEMENT LLC

Position in NEO — Neogenomics Inc

CIK 2100121 MALVERN, PA
Back to NEO Full portfolio

Position in NEO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$117,615,271
+$61,058,644 QoQ
Shares Held
8,061,362
+5.8% QoQ
Ownership
6.27%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#5
of 266 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

VANGUARD PORTFOLIO MANAGEMENT LLC holds $22,945,604,526 across 31 Diagnostics & Research names. NEO ranks #19 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 6,226,169 $3,121,552,089
2 DHR
Danaher Corp /De/
 14,205,213 $2,705,808,972
3 IDXX
Idexx Laboratories Inc /De
 3,896,521 $2,051,284,515
4 A
Agilent Technologies, Inc.
 14,442,441 $1,918,389,438
5 WAT
Waters Corp /De/
 4,740,524 $1,777,886,120
6 NTRA
Natera, Inc.
 5,782,640 $1,569,697,628
7 IQV
Iqvia Holdings Inc.
 7,501,993 $1,449,535,087
8 DGX
Quest Diagnostics Inc
 6,131,045 $1,299,474,987

All Filings in NEO

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $117,615,271 8,061,362
2026-03-31 $56,556,627 7,622,187